261 related articles for article (PubMed ID: 33937046)
1. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma.
Zhang Y; Yang X; Zhu XL; Wang ZZ; Bai H; Zhang JJ; Hao CY; Duan HB
Front Oncol; 2021; 11():643159. PubMed ID: 33937046
[TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment.
Zhang JJ; Zhang Y; Chen Q; Chen QN; Yang X; Zhu XL; Hao CY; Duan HB
J Inflamm Res; 2023; 16():895-916. PubMed ID: 36883185
[TBL] [Abstract][Full Text] [Related]
3. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
5. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
6. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
Dong T; Zhang B; Zhang R; Wang C; Liu X; Wang F; Hao N; Tan K; Chang YZ
Front Oncol; 2022; 12():963096. PubMed ID: 36237302
[TBL] [Abstract][Full Text] [Related]
8. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
[TBL] [Abstract][Full Text] [Related]
9. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
Front Genet; 2021; 12():718717. PubMed ID: 34925438
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.
Peng Z; Wu Y; Wang J; Gu S; Wang Y; Xue B; Fu P; Xiang W
Stem Cell Res Ther; 2023 Apr; 14(1):56. PubMed ID: 37005685
[TBL] [Abstract][Full Text] [Related]
12. New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma.
Zhou L; Jiang Z; Shi Z; Zhao W; Lu Z; Xie Y; Zhang B; Lu H; Tan G; Wang Z
Front Cell Dev Biol; 2021; 9():739097. PubMed ID: 34869322
[No Abstract] [Full Text] [Related]
13. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
14. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
[TBL] [Abstract][Full Text] [Related]
15. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Zhou Q; Zhou J; Fan J
Front Oncol; 2021; 11():638803. PubMed ID: 34094918
[TBL] [Abstract][Full Text] [Related]
16. High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma.
Guo Q; Gao X; Li J; Liu Y; Liu J; Yang H; Cui M; Zhang M; Duan L; Ma X
Sci Rep; 2023 Mar; 13(1):3820. PubMed ID: 36882457
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
PeerJ; 2020; 8():e8312. PubMed ID: 31921517
[TBL] [Abstract][Full Text] [Related]
18. HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma.
Yao Q; Ge X; Lu Z; Shi J; Shen J; Chen J
J Oncol; 2022; 2022():8027686. PubMed ID: 35865089
[TBL] [Abstract][Full Text] [Related]
19. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Peng S; Wang G; Cheng Z; Guo Z
Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of HDAC Family Identifies
Fan Y; Peng X; Wang Y; Li B; Zhao G
Front Mol Biosci; 2021; 8():720020. PubMed ID: 34540896
[No Abstract] [Full Text] [Related]
[Next] [New Search]